Financial statements Bella Pharma

Balance sheet of Bella Pharma

Company age:
Age:
9 y. 11 m. 10 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of BELLA PHARMA

Year
2018
2019
2020
2022
2023
Total assets 2 813 037,45 2 548 287,20 6 522 368,95 13 365 015,78 17 997 839,52
A. Fixed assets 33 715,71 128 477,98 2 023 421,86 92 300,86 7 989 499,39
B. Current assets 2 779 321,74 2 419 809,22 4 498 947,09 13 272 714,92 10 008 340,13
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00
Total liabilities 2 813 037,45 2 548 287,20 6 522 368,95 13 365 015,78 17 997 839,52
A. Equity 910 967,89 1 911 936,21 3 311 238,32 11 909 864,30 16 753 731,45
B. Liabilities and provisions for liabilities 1 902 069,56 636 350,99 3 211 130,63 1 455 151,48 1 244 108,07
I. Long-term liabilities 0,00 191 087,40 2 342 168,25 209 512,03 0,00
II. Short-term liabilities 1 902 069,56 293 093,71 642 264,47 789 557,59 830 421,62
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.